Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific transaction notification and does not contain comprehensive financial statements.
Material Changes
A revaluation of the cash element of the notional investment held within the US Retirement Savings Plan resulted in an increase in the notional allocation of GSK American Depositary Shares (ADSs). The transaction occurred on November 9, 2012, at a price of $43.55 per ADS.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items beyond the specific transaction notification. The transaction was notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
Investor Verification Points
- Transaction Date: November 9, 2012.
- Price per ADS: $43.55.
- Beneficiary: Dr K Slaoui (Connected Person of Director Dr M M Slaoui).
- Quantity: 5 ADSs allocated to the connected person; 0 ADSs allocated to the director.
- Plan Type: US Retirement Savings Plan (notional investment in GSK ADSs).